BioMark Diagnostics Inc (20B F) stock market data APIs
€0.1762
0(0%)
as of July 18, 2025
Try our APIs with
free plan!
BioMark Diagnostics Inc Financial Data Overview
Price chart is built with
Anychart
Biomark Diagnostics Inc., an oncology focused company, develops cancer diagnostic platform to detect, monitor, and treat cancer. The company invests in and develops liquid biopsy metabolic panel assay for early stage diagnosis of lung cancer. It has a strategic partnership with Rubix LS to develop diagnostic tools to enhance lung cancer screening and improve breast cancer screening program for women with dense breasts. The company was incorporated in 2014 and is headquartered in Richmond, Canada.
Prev. Close
0.1762
Open
0.1762
High
0.1762
Low
0.1762
52 wk Range
0.0985-0.202
Market Cap
19 282 K
Shares Outstanding
90 886 K
Revenue
155 K
Beta
-0.338
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get BioMark Diagnostics Inc data using free add-ons & libraries
Get BioMark Diagnostics Inc Fundamental Data
BioMark Diagnostics Inc Fundamental data includes:
- Net Revenue: 155 K
- EBITDA: -1 900 146
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
BioMark Diagnostics Inc News
New
BioMark Closes Second Tranche of Private Placement Offering
VANCOUVER, British Columbia, June 24, 2016 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. (“BioMark” or the “Company”) (CSE:BUX) (FSE:20B) (OTCQB:BMKDF) is pleased to announce that further to ...
BioMark Engages Stockhouse.com Deal Room with Private Placement
VANCOUVER, British Columbia, June 20, 2016 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. (“BioMark” or the “Company”) (CSE:BUX) (FSE:20B) (OTCQB:BMKDF) is pleased to announce it has engaged S...
BioMark Receives Approval for Its Lung Cancer Treatment Protocol
VANCOUVER, British Columbia, March 29, 2016 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. (“BioMark” or the “Company”) (CSE:BUX) (FSE:20B) (OTCQB:BMKDF) is pleased to announce that it has now...
BioMark Closes First Tranche of Private Placement Offering
VANCOUVER, British Columbia, March 15, 2016 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. (“BioMark” or the “Company”) (CSE:BUX) (FSE:20B) (OTCQB:BMKDF) is pleased to announce that further to...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
